ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
70.82
-0.18%
US Dollar vs AUD
1.44437
-0.45%
Bitcoin
65,839.83
1.01%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biofrontera Inc (BFRIW)

  7. Biofrontera Inc (BFRIW) News

BFRIW

Biofrontera (BFRIW)

Biofrontera Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BFRIW
DateTimeSourceHeadlineSymbolCompany
12/09/202423:46Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BFRIWBiofrontera Inc
15/08/202406:30GlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
24/06/202422:30GlobeNewswire Inc.Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampNASDAQ:BFRIWBiofrontera Inc
15/06/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
23/05/202406:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BFRIWBiofrontera Inc
23/05/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
16/05/202407:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
10/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
17/12/202200:30GlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIWBiofrontera Inc
01/12/202206:08GlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
29/11/202203:05GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIWBiofrontera Inc
22/11/202200:48GlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIWBiofrontera Inc
15/11/202200:45GlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
11/11/202203:52GlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIWBiofrontera Inc
09/11/202208:45GlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
31/10/202223:55GlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
24/10/202222:45GlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIWBiofrontera Inc
21/10/202202:40GlobeNewswire Inc.Biofrontera Inc. to Present at the LD Micro Main Event XV Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
19/10/202201:30GlobeNewswire Inc.Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology ConferenceNASDAQ:BFRIWBiofrontera Inc
14/10/202223:40GlobeNewswire Inc.Biofrontera Inc. Adopts Limited Duration Shareholder Rights PlanNASDAQ:BFRIWBiofrontera Inc
13/10/202205:00GlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022NASDAQ:BFRIWBiofrontera Inc
06/10/202208:00GlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
30/09/202200:04GlobeNewswire Inc.Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities ConferenceNASDAQ:BFRIWBiofrontera Inc
26/09/202222:30GlobeNewswire Inc.Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer AwardsNASDAQ:BFRIWBiofrontera Inc
13/09/202222:30GlobeNewswire Inc.Biofrontera Inc. Names Gerard DiGirolamo as National Sales DirectorNASDAQ:BFRIWBiofrontera Inc
07/09/202200:31GlobeNewswire Inc.Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. PatentNASDAQ:BFRIWBiofrontera Inc
19/08/202201:04GlobeNewswire Inc.Biofrontera Inc.’s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for DermatologyNASDAQ:BFRIWBiofrontera Inc
12/08/202222:33GlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
04/08/202222:30GlobeNewswire Inc.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022NASDAQ:BFRIWBiofrontera Inc
02/08/202201:00GlobeNewswire Inc.Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbHNASDAQ:BFRIWBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRIW

Your Recent History

NYSE
MRK
Merck
ASX
WPL
Woodside Petroleum
ASX
TLS
Telstra
ASX
RIO
Rio Tinto
ASX
AMP
AMP
COIN
DOGEUSD
Dogecoin
ASX
ORG
Origin Energy
COIN
XRPUSD
Ripple
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
FX
EURAUD
Euro vs AUD
COIN
SOLUSD
Solana
ASX
XJO
S&P ASX 200
ASX
NAB
National Australia Bank
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved